ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

OCC to Take Over CIS Oct; Cost Sharing “Is Dead”

July 15, 1988

Freireich’s Seven Laws To Protect Against Obstacles To Clinical Research

May 14, 1976

In Brief: New Clinical Education Program Guidelines Due; Maryland Has First Mammography Screening Law

May 30, 1986

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986